chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Neuropathy in arms and hands. Numbness. tingling. Some loss of dexterity.
Dizziness, vertigo, insomnia, extreme unrelenting panic attacks, light-headedness, jittery, chills, cold and clammy, body wide tremors, nausea, restless legs, shaky hands and vision, racing heart, unable to stand for any amount of time, arms and legs are numb and feel "light", cloudy thinking, emotionless, unable to make eye contact with others. I feel "strange".  It feels like my body is floating and i have no control over my limbs. These symptoms started at 10:00 pm on Aug `19 and lasted until today Aug 21. They are unremitting still but the intensity has subsided since morning of Aug 21.
Right arm is red, swollen, tingling felt in hands and fingers. No fever. Also felt numbness sharp pain when making a fist. No oozing or bleeding present. States skin is very sensitive.
I got dizzy; blurred vision; fainted and fell on the floor the next morning; fainted and fell on the floor the next morning; Other vaccine same date vaccine date 08Oct2021: Flu Shot; dose number=3 on 08Oct2021; dose number=3 on 08Oct2021; vaccine location=Left leg; This is a spontaneous report from a contactable consumer. A 94-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 3 via an unspecified route of administration, administered in Leg Left at age of 94-years-old on 08Oct2021 10:30 (Lot Number: 30130A) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE) (reported as Flu Shot), via an unspecified route of administration on 08Oct2021 (Batch/Lot number was not reported), at single dose for immunisation. Medical history Afib, high blood pressure, history of bladder and breast cancer, osteoarthritis. Concomitant medication(s) included metoprolol tartrate; furosemide; tamoxifen; omeprazole; rivaroxaban (XARELTO) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 at age of 93 year old on 27Jan2021 (Batch/Lot No: e3302) Arm Left and second dose of BNT162B2 at age of 93 year old on 17Feb2021 (Batch/Lot No: EN6200) Arm Left for COVID-19 immunization. The patient experienced adverse event: I got dizzy, blurred vision, fainted and fell on the floor the next morning. I was sent to the hospital by ambulance on 09Oct2021 09:30. The patient was hospitalized for events from 10Oct2021 for 3 days. Treatment of events was unknown. Outcome of events was unknown. Evens required Emergency room/department or urgent care.
Stuttering. He never stuttered at all. He loved to talk and talked clearly. Now he stutters over every word he says and doesn't want to talk anymore.
Heart attack; Asthma attacks; This is a spontaneous report from a contactable consumer (the patient). An 82-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in Left Arm on 16Mar2021 10:00 (Batch/Lot Number: EN6206; Expiration Date: 30Jun2021) as single dose for COVID-19 immunization. Medical history included asthma from an unknown date (she has had Asthma for about 14-15 years), broke back from an unknown date (she broke her back about 3 years ago); stent placement from an unknown date (she had 2 heart stents placed about 2 years ago), and then she said she was allergic to a couple of fairly common medicines (statins and NSAIDs) from an unknown date. There were no concomitant medications. The patient received her first Pfizer COVID-19 Vaccine on 16Mar2021. She said she would really like to know if the COVID-19 Vaccine possibly caused her to have the worse asthma attack she ever had in her life on 17Mar2021. She clarified she was talking to her friend on the telephone when she had her asthma attack at 3:30PM. She said that on 18Mar2021 at 5:00AM, she had a second asthma attack. She said her second asthma attack was not as bad as the one she had on 17Mar2021. For her first asthma attack on 17Mar2021, she took 2 puffs from her inhaler, and then an additional 2 puffs (4 puffs total). She said her doctor told her if she had a bad asthma attack, she could take 2 more puffs from the inhaler. She said she normally takes 2 puffs from her inhaler. She said for her second asthma attack on 18Mar2021 she took only 2 puffs from her inhaler. After she took her 2 puffs from her ProAir HFA Albuterol Sulfate inhaler, she flopped back into her bed. She reported she normally has 3-4 asthma attacks a year. She reported that her doctor did a complete blood workup on 03Mar2021 and told her she was doing just lovely. The patient also reported she had a very mild heart attack and she can't even take low dose aspirin. The patient also reported she had another question about the COVID-19 Vaccine. She said she was allergic to a couple of fairly common medicines (statins and NSAIDs) and wanted to know if anything in the list of the COVID-19 Vaccine ingredients would indicate her having a possible allergy to the vaccine. The events did not require a visit to Emergency Room and/or Physician Office. The outcome of the event asthma attack was recovering, and for the heart attack was unknown.
Pt received Tdap, Gardasil9, Menveo on 8/14/19. Pt had seizure on 8/18 x3. Required ER visit & then transfer admission to PICU. MRI & EEG neg. No prior hx of seizures. D/c hosp 8/20/19. Put on Keppra 600mg BID by neurology.
Reported lump in her throat and coolness of left arm which was treated with Benadryl 25 mg po; HR=84 and BP=128/88; then had severe cramping in right leg with foot numbness; patient transported to the Emergency Department
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had been administered dose of GARDASIL on 16-APR-2013 (lot number: H011350; exp date: 21-FEB-2015) (dose, frequency, route and site of administration were not reported). No adverse event was reported. This is one of the reports from the same source. Additional information is not expected.
This spontaneous report was received from a health care worker regarding an unspecified number of patients of unknown age and gender. Information on their concurrent condition, medical history and drug allergies were not reported. On 11-APR-2016, unspecified patients were vaccinated with 2 doses of improperly stored GARDASIL 9 and on 12-APR-2016, 13-APR-2016 and 18-APR-2016 with 1 dose and on 20-APR-2016 with 3 doses of GARDASIL 9 lot # L044475, expiry date 12-MAY-2017, (dose number, route and anatomical location were not specified). Concomitant medication were not reported. There were no adverse events reported. There was no product quality complaint (PQC) involved. The vaccine administered was maintained at a temperature of 58 degree Fahrenheit for a time frame of 1.5 hours. This case is also linked to MARRS#1605USA009599 (same reporter link). Additional information has been requested.
SEVERE UNUSUAL PAIN AT SHOULDERS BILATERALLY. OCT I 7PM UNABLE TO USE EITHER HAND OR FINGERS. SHAKING OF HANDS. OCT 3-8 PROGRESSIVE LOSS OF USE OF ABILITY TO MOVE LEGS. WAS USING CANE THEN WALKER THEN WHEELCHAIR.  DIFFICULT TRANSFER BUT COULD BEAR WT ON FEET IF WE COULD GET HER UP SHE HAD SEVERE LOWER BACK PAIN WITH INABILITY TO STAND THE SLIGHTEST TOUCH SHOULDERS ESPECIALLY LEFT ALSO SEVERE PAIN. THESE SYMPTOMS STABILLIZED PAIN CONTROLLED WITH TRAMADOL. NO FURTHER PROGRESSION HOWEVER HR IRREGULAR, FATIGUE INCREASED WITHOUT BREATHING DISABILITY. SOME IMPROVEMENT NOTED IN USE OF LEFT HAND AND RIGHT FINGERS BUT NO PINCER STRENGTH OR SQUEEZE.  ABILITY TO WALK WITH WALKER HAS NOT RETURNED.
Information has been received from a pharmacist via a company representative referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided. In August 2015 (reported as a year ago), the patient was vaccinated with a dose of ZOSTAVAX (dose, lot # and route unknown). In approximately October 2015, 2 months after receiving ZOSTAVAX, the patient developed Bell's Palsy. The outcome of the event was unknown. The causality was not provided. Upon internal review, Bell's Palsy was considered to be medically significant. Additional information has been requested.
BODY ACHING; CHILLS; PAIN DURING INJECTION; FEVER 100.9; This spontaneous report received from a patient concerned a 57 year old of unspecified sex. The patient's weight, height, and medical history were not reported.  The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 12:20 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced body aching. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced pain during injection. On 08-APR-2021, the subject experienced fever 100.9. Treatment medications included: paracetamol. The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aching, chills, and fever 100.9 on 09-APR-2021, and pain during injection on 08-APR-2021. This report was non-serious.
Returned to clinic 11 days after vaccine rec'd with dermatologic reaction on forehead above (R) eye. Clear, weeping vesicles as well as crusted, dry vesicles present, approximately 2 sq in. on forehead. Denies itching, pain, or fever. Slight edema also noted at site. Agreed to contact primary care physician immediately to be evaluated.
Administration: technician uncapped syringe needle with her teeth, laid exposed needle by computer keyboard while typing and continuing to talk with needle cap in mouth. Drew up vaccine with contaminated needle, then changed needle prior to injection. Inflamed, infected injection site.
Bruising, pain, warmth. Can't raise arm up. Advised to see MD.
pt recvd 3 doses of Engerix-B & 1 yr following last dose 22JAN91 pt devel bell's palsy which continues;
Administration Error: 12 children at a recent community vaccination event erroneously received ~25.7mcg of the adult Pfizer formulation instead of the intended 10mcg dose. In this case, the vaccine mixer pulled the Pfizer vaccine for adults/adolescents (purple top; for 12 years +) from the cooler instead of the intended Pfizer Pediatric (orange top; for 5-11 years).  He proceeded to prepare the Adult Pfizer vials following the Pfizer instructions (diluted with 1.3mL diluent and prepared 0.2mL into syringe).  These doses were administered to 12 patients before the error was identified.  All patients did not report any adverse effects during the immediate observation phase, or during phone call follow-up several days following the event.  All patients/parents have been notified of the error, advised that the CDC considers this a valid 1st dose, and will proceed to receive the 2nd dose as scheduled.  Mixing procedures and workflows have been evaluated and adjusted per our safety action plan as a result of this error.
Excessive thirst, couldn?t get enough to drink. Mouth was extremely dry. Started the day of shot lasted about three days. There was also a dry cough. Started the day of the shot, it would come in fits, and it could be pretty bad. The second day had the worst coughing fit. After that the coughing went away. I drank a lot of water for that symptom. I did nothing really for the coughing.
pt recvd vax 10NOV95 & sl puffiness of face & hands;12NOV95 diarrhea;14NOV95 c/o about shoes tight & sore feet;pt began to see red spots on chest, back & on feet;noticed some swelling of feet;hives, chicken pos-more info see original report
Child received varicella vaccine 2/25/03.  Reported to clinic 3/24/03 with papular rash, dx insect bites.  Returned 3/28/03 with rash all over body, dx with mild chicken pox.
Itchy throat/ itching inside throat area; Itching in the inside of ears; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 12Apr2021 at 17:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease (years in remission). Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date and unknown if ongoing. The patient previously received Propranolol, Augmentin, Keflux, Septra, Besivance, Erythromycin, Protonix, Ranitidine, Nexium and Omeprazole and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 17:45 approximately 37 minutes after vaccination, the patient experienced an itchy throat and itching in the inside of her ears inside her throat area. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events Itchy throat and itching in the inside of ears was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Given an Injection of Heplisav-B Which Had Been Out of Temperature Range for Greater Than 8 Hours; Initial Report Received on 27-Feb-2023.  A registered nurse reported that a 35-year-old male patient (race and ethnicity unknown) received a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization that was out of temperature range for greater than eight hours.  Medical history was unknown and concomitant medications at the time of vaccination were not reported. The patient had no known drug allergies.  On 06-Feb-2023, the patient received a dose of HEPLISAV-B vaccine (Lot # 937228, expiration date 30 Aug-2023, NDC # 43528-0003-05) intramuscularly in the left deltoid. The HEPLISAV-B dose that the patient received had been out of temperature range for greater than eight hours. No adverse effects were reported.  No further information was available.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium
My heart began to beat rapidly, and I felt as if I were going to faint approximately one hour after receiving the vaccines (Td and Hep B).  The room darkened, everything looked wavy, and sounds were far away.  This feeling passed after a few minutes, but I still felt lightheaded and nauseous afterward.  I was running a fever (about 100.5) for that night and the next (102).  Today, three days afterward, I still have a fever (101 F).  Also, every bone in my body aches.  I called the clinic so they could note my symptoms, and will go in to be seen on Monday 4/26/10 if my symptoms have not subsided.
pt recv vax;exp erythema lt leg & arms w/ irritability in the eve;
pt recv vax 07jun95; 14jan97 pt devel a full blown case of chickenpox described as classic chickenpox; pt recovered 21jan97
got sick; Initial information received on 07-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient).   This case involved an adult patient of an unknown age and gender who got sick (Illness), after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date and other dosing details were not reported) via unknown route in unknown administration site.    On an unknown date, unknown latency, the patient took the flu shot and got sick (illness), never got one since.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome of the event was reported as unknown.  There will be no information available on the batch number for this case.
Severe headache evening after vaccine. Sleepless night B/C of headache. Thursday noon trouble breathing went to ER.
very hard pain; I am sick; vaccine made me sick; my doctor said I have to pleurisy it's some summation; I can not sleep well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11Sep2021 (Lot number: FC3186) at the age of 34 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "breast feed my baby", start date: 2021, stop date: 2021. Concomitant medication(s) included: IBUPROFEN. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE , Lot # EY0584, Route of administration: Intramuscular, Anatomical site: Left arm), administration date: 13Aug2021. The following information was reported: PAIN (non-serious), outcome "unknown", described as "very hard pain"; ILLNESS (non-serious), outcome "unknown", described as "I am sick; vaccine made me sick"; PLEURISY (non-serious), outcome "unknown", described as "my doctor said I have to pleurisy it's some summation"; SLEEP DISORDER (non-serious), outcome "unknown", described as "I can not sleep well". The events "very hard pain" and "my doctor said i have to pleurisy it's some summation" were evaluated at the emergency room visit.  Additional information: The patient stated that I was in the emergency room. I'm sorry my language is not so well, I'm trying to explain. I had a very hard pain. I was checking with my doctor and my doctor said I have the, this like I am sick. The vaccine made me sick so now my doctor said I have to pleurisy it's some summation, the line that is going around my lungs (Further Not Clarified). It's the line going around the lungs and my doctor say it because it is for that second dosage of the COVID-19. Now I take Ibuprofen (Treatment) for the pain because I have a baby, I'm breast feed my baby. So I can't take any other medication. That's what I'm taking now for the pain. Yeah that's what my doctor recommended to take Ibuprofen. There was no other Prior vaccination (4 weeks).   No follow-up attempts are possible. No further information is expected.
Patient was administered 1 dose of Moderna vaccine at drive-thru vaccination clinic although he is not 18.  Parent notified and he is not having any adverse reactions to vaccination.
Progressive neurological issues, including short-term memory loss, and hand trembling.  Tingling more often from the foot up to the knee has diabetic neuropathy.  Symptoms have progressively worse since the vaccine.
Information has been received from a physician concerning an approximately 17 year old female who was vaccinated intramuscularly with the first dose of Gardasil vaccine. At this time, the patient also received Menactra. The patient experienced vomiting the same day. The patient was vaccinated with the second and third doses of Gardasil vaccine and again experienced vomiting. The patient recovered on an unspecified date. The patient sought unspecified medical attention by contacting the physician. Dates for the administration of the vaccine series were not available. No further information provided. Additional information has been requested. Information has been received from a physician concerning an 18 year old female withno medical history who on 02-FEB-2207 and 17-APR-2007 was vaccinated IM with a first and second 0.5ml dose of HPC vaccine (Lot #655617/1447F and 656051/0244U) respectively. It was reported that the patient vomited one time, four hours after each dose. Unspecified medical attention was sought. No laboratory diagnostic studies were performed. At the time of this report, the patient recovered. No product quality complaint was involved. Additional information is not expected.
Child got a small rash on the right side of his trunk up near the breast and armpit. The rash didn't appear to effect him in anyway however by 2/4/2017 the rash began to spread over the rest of his trunk, extremities, and face. The original site of the rash also appeared to become itchy.
No additional AE; a patient, who was originally on the 2 dose regimen of GARDASIL 9, received a third dose inadvertently.; 1st Dose: Administered on 24JUL2017; 2nd Dose: Administered on 28-AUG-2018; This spontaneous report was received from a medical assistant, referring to a 16-year-old male patient. Information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was not provided.  On 24-JUL-2017, the patient was vaccinated with the first dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) vial, dose at 0.5 mL, lot number M041990 was confirmed to be valid, expiration date 28-JUN-2019 (route of administration and anatomical location were not reported) for prophylaxis.  On 28-AUG-2018, the patient was vaccinated with the second dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) vial, dose at 0.5 mL, lot number N025429 was confirmed to be valid, expiration date was reported as 21-MAY-2020 but upon internal validation process, it was established as 21-JUL-2020 (route of administration and anatomical location were not reported) for prophylaxis (inappropriate schedule of product administration). On 21-MAR-2022, the patient was inadvertently vaccinated with the third dose of hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, dose at 0.5 mL, lot number 1687293 was confirmed to be valid (discrepant information, also reported as 1678293; lot number 1678293 is an invalid lot number for hpv rL1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). Lot number 1687293 does not match any Company product as confirmed by Lot Verification team), expiration date 30-APR-2023 (route of administration and anatomical location were not reported) for prophylaxis (extra dose administered). The caller also stated the 1st and 2nd dose were not administered at their clinic. The patient was originally on the 2 dose regimen of the vaccine. No additional adverse event (AE) (no adverse event).
Small blisters near area vaccine given. Could have been reaction to adhesive on Band-Aid.
Muscle pain (arms, legs, back, and neck), weakness and shakiness in legs, redness, swelling, and pain at injection site.
During a review of the Health Department's internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
Started with a cough within an hour and a half after the vaccine. Felt as if my throat was closing and became a little difficult to breathe. Next day woke up to bloodshot eyes, and body aches. No more throat issues though. Two days later - better one hip joint still hurts - feel a little light headed but otherwise ok